Algorithm created to analyse large single-cell sequencing datasets
An algorithm which continuously processes new data has been developed to allow researchers to access and analyse single-cell sequencing information.
List view / Grid view
An algorithm which continuously processes new data has been developed to allow researchers to access and analyse single-cell sequencing information.
A new COVID-19 vaccine could provide protection from severe infection from a range of coronaviruses, studies in pigs have shown.
Researchers have used CRISPR to create a new technology that can switch off almost any gene in cells, called CRISPRoff.
The drug MK-4482 decreased viral levels in the lungs of hamsters treated for SARS-CoV-2 infection, researchers have shown.
Scientists have created an assay to detect the protein cathepsin B in blood, a biomarker for a range of diseases.
By increasing the frame rate of atomic force microscopy to 30 frames per second, scientists found the technique was faster and less invasive.
Researchers have shown how different viruses such as HSV-1 and Zika can lead to microcephaly using brain organoids.
Researchers have developed an artificial intelligence to identify the best potential antibody drug from groups of up to a few thousand.
An international collaboration has led to the development of monkey embryos able to grow with injected human stem cells.
A study has shown that treatments to reduce levels of hydrogen sulphide (H2S) in the brain may help to prevent dementia.
Novel organoid models of cervical cancer and a healthy human cervix have been developed to study the condition and its progression.
A team has demonstrated in mouse models that a self-assembling nanofibre material could limit the damage caused by cytokines in inflammatory diseases.
Researchers have used fragment screening alongside computational docking to reveal 20 hit antiviral compounds against SARS-CoV-2.
Scientists have discovered that manipulating residues enables precision during the antibiotic biosynthesis assembly line.
Delivering Txnip to mice with retinitis pigmentosa was an effective treatment, making this approach a potential gene therapy for the disease.